Crossject signs ZEPIZURE® commercialization agreement for

Crossject to receive up to €1 million on marketing approvals, plus a markup on sales linked to gross margin Agreement, with undisclosed strategic partner,...

Related Keywords

Denmark ,Finland ,France ,Norway ,United Kingdom ,New Zealand ,Australia ,Sweden ,Germany ,Patrick Alexandre ,Natasha Drapeau ,Sophie Baumont ,Biomedical Advanced Research ,Us Biomedical Advanced Research ,Cohesion Bureau ,Euronext ,Development Authority ,Advanced Research ,Paris Stock Exchange Alcj ,Crossject ,Commercialization Agreement ,Epilepsy ,Elf Injection System ,Ccord De Commercialisation ,Uto Injecteurs ,33 Pilepsie ,